Literature DB >> 19701734

[Osteoporosis--current diagnostics and therapy].

Johannes Pfeilschifter1.   

Abstract

Osteoporotic fractures are a frequent cause of disability and a loss of quality of life in old age. Maintenance of muscle function and balance, a daily calcium intake of 1,000 mg, sufficient vitamin D, and a prudent use of fall- and osteoporosis-associated drugs are key components of fracture prevention. The German guideline recommends to initiate a specific long-term osteoporosis medication in individuals with a 30% 10-year risk for hip fractures and vertebral fractures.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19701734     DOI: 10.1007/s00063-009-1135-2

Source DB:  PubMed          Journal:  Med Klin (Munich)        ISSN: 0723-5003


  16 in total

1.  Can you diagnose for vertebral fracture correctly by plain X-ray?

Authors:  Z Ito; A Harada; Y Matsui; M Takemura; N Wakao; T Suzuki; T Nihashi; S Kawatsu; H Shimokata; N Ishiguro
Journal:  Osteoporos Int       Date:  2006-08-18       Impact factor: 4.507

Review 2.  Consensus development conference: diagnosis, prophylaxis, and treatment of osteoporosis.

Authors: 
Journal:  Am J Med       Date:  1993-06       Impact factor: 4.965

3.  Constant adaptation of bone to current physical activity level in men: a 12-year longitudinal study.

Authors:  Taru Tervo; Peter Nordström; Martin Neovius; Anna Nordström
Journal:  J Clin Endocrinol Metab       Date:  2008-09-30       Impact factor: 5.958

4.  A meta-analysis of previous fracture and subsequent fracture risk.

Authors:  J A Kanis; O Johnell; C De Laet; H Johansson; A Oden; P Delmas; J Eisman; S Fujiwara; P Garnero; H Kroger; E V McCloskey; D Mellstrom; L J Melton; H Pols; J Reeve; A Silman; A Tenenhouse
Journal:  Bone       Date:  2004-08       Impact factor: 4.398

Review 5.  Vitamin D deficiency: a worldwide problem with health consequences.

Authors:  Michael F Holick; Tai C Chen
Journal:  Am J Clin Nutr       Date:  2008-04       Impact factor: 7.045

6.  Risk of hip fracture after bisphosphonate discontinuation: implications for a drug holiday.

Authors:  J R Curtis; A O Westfall; H Cheng; E Delzell; K G Saag
Journal:  Osteoporos Int       Date:  2008-05-16       Impact factor: 4.507

7.  Fracture outcomes related to persistence and compliance with oral bisphosphonates.

Authors:  Arlene M Gallagher; Stephan Rietbrock; Melvin Olson; Tjeerd P van Staa
Journal:  J Bone Miner Res       Date:  2008-10       Impact factor: 6.741

Review 8.  Is a change in bone mineral density a sensitive and specific surrogate of anti-fracture efficacy?

Authors:  E Seeman
Journal:  Bone       Date:  2007-06-26       Impact factor: 4.398

9.  Risk for fracture in women with low serum levels of thyroid-stimulating hormone.

Authors:  D C Bauer; B Ettinger; M C Nevitt; K L Stone
Journal:  Ann Intern Med       Date:  2001-04-03       Impact factor: 25.391

10.  Ten-year fracture probability identifies women who will benefit from clodronate therapy--additional results from a double-blind, placebo-controlled randomised study.

Authors:  E V McCloskey; H Johansson; A Oden; S Vasireddy; K Kayan; K Pande; T Jalava; J A Kanis
Journal:  Osteoporos Int       Date:  2008-11-11       Impact factor: 4.507

View more
  2 in total

1.  [The Ludwigshafen Osteoporosis Screening Questionnaire (LOS Questionnaire): result of the evaluation of anamnestic risk factors in osteoporosis diagnostics].

Authors:  C Wölfl; C Takur; A A Moghaddam; G Zimmermann; M Hitzler; H Schmidt-Gayk; B Höner; P A Grützner; L Kolios
Journal:  Unfallchirurg       Date:  2013-02       Impact factor: 1.000

2.  Anamnestic risk factor questionnaire as reliable diagnostic instrument for osteoporosis (reduced bone morphogenic density).

Authors:  Leila Kolios; Caner Takur; Arash Moghaddam; Mirjam Hitzler; Heinrich Schmidt-Gayk; Arnold J Suda; Bernd Höner; Paul A Grützner; Christoph Wölfl
Journal:  BMC Musculoskelet Disord       Date:  2011-08-17       Impact factor: 2.362

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.